 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | CD19/CD22 dual-target CAR-T / Shenzhen University General Hospital
New P1/2 trial, CAR T-Cell Therapy: Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Jan 26, 2021
P1/2, N=20, Recruiting, Sponsor: Shenzhen University General Hospital